Aquestive Therapeutics
AQST
AQST
42 hedge funds and large institutions have $35M invested in Aquestive Therapeutics in 2020 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 20 increasing their positions, 11 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
65% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 20
65% less capital invested
Capital invested by funds: $101M → $35M (-$66.1M)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $2K
Holders
42
Holding in Top 10
2
Calls
–
Puts
$2K
Top Buyers
| 1 | +$1.2M | |
| 2 | +$471K | |
| 3 | +$383K | |
| 4 |
JPMorgan Chase & Co
New York
|
+$209K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$141K |
Top Sellers
| 1 | -$4.3M | |
| 2 | -$2.65M | |
| 3 | -$932K | |
| 4 |
Two Sigma Investments
New York
|
-$835K |
| 5 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$654K |